title: Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
abstract: beta-Catenin/Tcf and NF-kappaB pathways play an important role in biological functions. We determined the underlying mechanisms of differential interaction between two pathways in various human cancer cell lines. NF-kappaB positively regulated beta-catenin/Tcf pathways in human glioblastoma, whereas it has an opposite effect on beta-catenin/Tcf pathways in colon, liver, and breast cancer cells. Expression of lucine zipper tumor suppressor 2 (lzts2) was positively regulated by NF-kappaB activity in colon, liver, and breast cancer cells, whereas negatively regulated in glioma cells. Downregulation of lzts2 increased the beta-catenin/Tcf promoter activity and inhibited NF-kappaB-induced modulation of the nuclear translocation of beta-catenin. These data indicate that the differential crosstalk between beta-catenin/Tcf and NF-kappaB pathway in various cancer cells is resulted from the differences in the regulation of NF-kappaB-induced lzts2 expression.
authors.affiliation: Department of Physiology, School of Medicine, Pusan National University, Suh-Gu, Pusan, Republic of Korea.
authors.forename: Hyun Hwa
authors.initials: HH
authors.lastname: Cho
authors.forename: Ji Sun
authors.initials: JS
authors.lastname: Song
authors.forename: Ji Min
authors.initials: JM
authors.lastname: Yu
authors.forename: Sung Sook
authors.initials: SS
authors.lastname: Yu
authors.forename: Sung Jong
authors.initials: SJ
authors.lastname: Choi
authors.forename: Dong Heon
authors.initials: DH
authors.lastname: Kim
authors.forename: Jin Sup
authors.initials: JS
authors.lastname: Jung
mesh_terms: D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D015536:Down-Regulation / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008954:Models, Biological; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D010455:Peptides / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D051820:TCF Transcription Factors / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism; D051176:beta Catenin / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; C440108:LZTS2 protein, human; D016328:NF-kappa B; D010455:Peptides; C118258:SN50 peptide; D051820:TCF Transcription Factors; D025521:Tumor Suppressor Proteins; D051176:beta Catenin